532067 — 3B Blackbio DX Cashflow Statement
0.000.00%
- IN₹13.56bn
- IN₹12.89bn
- IN₹964.69m
- 98
- 13
- 36
- 48
Annual cashflow statement for 3B Blackbio DX, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | C2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 1,520 | 432 | 353 | 443 | 640 |
Depreciation | |||||
Non-Cash Items | 2.28 | 1.06 | -24.2 | -56.7 | -59.5 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -554 | -66.8 | -135 | -128 | -158 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 975 | 373 | 203 | 270 | 434 |
Capital Expenditures | -16.8 | -22.6 | -20.2 | -5.08 | -9.04 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -686 | -262 | 168 | -198 | -329 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -703 | -284 | 147 | -203 | -338 |
Financing Cash Flow Items | -0.492 | -1.34 | -1.25 | -3.23 | -1.08 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -15.7 | -151 | -50.1 | -36.3 | -32.2 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 257 | -61.9 | 303 | 29.4 | 66.8 |